UK researchers analyzed data on 130 patients with type 2 diabetes from the MEMO study and found that those who participated in a multifactorial intervention experienced greater reductions in A1C, systolic and diastolic blood pressure, total cholesterol and LDL cholesterol over four years, compared with the standard care group. Published in Diabetic Medicine, findings showed that those in the intervention group also had larger reductions in 10-year risk scores for coronary heart disease and stroke than the standard care group.
Multifactorial intervention tied to A1C, BP reduction in diabetes
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.